Sponsor:
University of Vermont
Code:
NCT07005024
Conditions
Cancer
VTE (Venous Thromboembolism)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Apixaban 2.5 mg twice daily
Apixaban 5 mg once daily
No anticoagulation
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-31. This information was provided to ClinicalTrials.gov by University of Vermont on 2026-02-05.